Bridging the new drug access gap between China and the United States and its related policies

Introduction: The access gap for novel pharmaceuticals between China and the developed countries is a major public health issue in China. It is crucial to understand the determinants of this gap to ensure timely access to new drugs and enhance patient health. Methods: We included all new drugs appro...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 14; p. 1296737
Main Authors Zhu, Xingyue, Chen, Yang
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 08.01.2024
Subjects
Online AccessGet full text

Cover

Loading…